Fatigue is a core systemic feature of Sjogren's, affecting 70-96% of patients.

On January 30, the Sjogren's Foundation's 2026 State of Sjogren’s CME Conference featured six new drugs currently in clinical trials. I share highlights from the conference and discuss how clinical studies might impact Sjogren’s care going forward.  

Neuropathy affects over half of Sjogren's patients but is often overlooked.

I share how I am monitored as a long-standing Sjogren's patient to provide an example of comprehensive care.